GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sanara MedTech Inc (NAS:SMTI) » Definitions » Cyclically Adjusted PB Ratio

Sanara MedTech (Sanara MedTech) Cyclically Adjusted PB Ratio : 77.02 (As of Apr. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Sanara MedTech Cyclically Adjusted PB Ratio?

As of today (2024-04-27), Sanara MedTech's current share price is $32.35. Sanara MedTech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $0.42. Sanara MedTech's Cyclically Adjusted PB Ratio for today is 77.02.

The historical rank and industry rank for Sanara MedTech's Cyclically Adjusted PB Ratio or its related term are showing as below:

SMTI' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 77.02   Med: 93.44   Max: 256.88
Current: 77.88

During the past years, Sanara MedTech's highest Cyclically Adjusted PB Ratio was 256.88. The lowest was 77.02. And the median was 93.44.

SMTI's Cyclically Adjusted PB Ratio is ranked worse than
99.78% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs SMTI: 77.88

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sanara MedTech's adjusted book value per share data for the three months ended in Dec. 2023 was $5.253. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.42 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sanara MedTech Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sanara MedTech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanara MedTech Cyclically Adjusted PB Ratio Chart

Sanara MedTech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 98.94

Sanara MedTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 190.95 98.94

Competitive Comparison of Sanara MedTech's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Sanara MedTech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanara MedTech's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sanara MedTech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sanara MedTech's Cyclically Adjusted PB Ratio falls into.



Sanara MedTech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sanara MedTech's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=32.35/0.42
=77.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanara MedTech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Sanara MedTech's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=5.253/129.4194*129.4194
=5.253

Current CPI (Dec. 2023) = 129.4194.

Sanara MedTech Quarterly Data

Book Value per Share CPI Adj_Book
201403 -0.487 99.695 -0.632
201406 -1.138 100.560 -1.465
201409 -1.597 100.428 -2.058
201412 -1.450 99.070 -1.894
201503 -1.531 99.621 -1.989
201506 0.000 100.684 0.000
201509 -1.727 100.392 -2.226
201512 -1.932 99.792 -2.506
201603 -1.579 100.470 -2.034
201606 -1.603 101.688 -2.040
201609 -1.434 101.861 -1.822
201612 -1.166 101.863 -1.481
201703 -1.017 102.862 -1.280
201706 -0.945 103.349 -1.183
201709 -0.967 104.136 -1.202
201712 -0.664 104.011 -0.826
201803 0.716 105.290 0.880
201806 0.734 106.317 0.893
201809 0.673 106.507 0.818
201812 -4.556 105.998 -5.563
201903 -5.114 107.251 -6.171
201906 -5.263 108.070 -6.303
201909 -5.617 108.329 -6.711
201912 -1.331 108.420 -1.589
202003 1.093 108.902 1.299
202006 0.942 108.767 1.121
202009 0.932 109.815 1.098
202012 0.977 109.897 1.151
202103 4.724 111.754 5.471
202106 4.612 114.631 5.207
202109 4.442 115.734 4.967
202112 3.991 117.630 4.391
202203 3.717 121.301 3.966
202206 4.516 125.017 4.675
202209 5.474 125.227 5.657
202212 5.040 125.222 5.209
202303 4.964 127.348 5.045
202306 4.876 128.729 4.902
202309 5.189 129.860 5.171
202312 5.253 129.419 5.253

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sanara MedTech  (NAS:SMTI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sanara MedTech Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sanara MedTech's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanara MedTech (Sanara MedTech) Business Description

Traded in Other Exchanges
N/A
Address
1200 Summit Avenue, Suite 414, Fort Worth, TX, USA, 76102
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel.
Executives
Eric D Major director 751 MILLER DRIVE SE, LEESBURG VA 20175
Zachary B. Fleming officer: President - Surgical Div. 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Shawn M. Bowman officer: President - Wound Care Div. 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Rebecca E Mcmahon officer: President - R&D 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Sara N Ortwein director 5959 LAS COLINAS BOULEVARD, IRVING TX 75039-2298
Robert Andrew Desutter director 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Eric D Tanzberger director 1929 ALLEN PARKWAY, HOUSTON TX 77219
Christopher A. Morrison officer: President - Telehealth Svcs. 1200 SUMMIT AVENUE, SUITE 414, FORT WORTH TX 76102
Roszell Iii Mack director 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Cgi Cellerate Rx, Llc 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
Catalyst Rochal, Llc 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
Bradley J. Gurasich 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
J Michael Carmena director, officer: Principal Executive Officer 1200 SUMMIT AVE STE 414, FORT WORTH TX 76102
Michael D. Mcneil officer: Chief Financial Officer 1200 SUMMIT AVE, STE 414, FORT WORTH TX 76102
Catalyst Group, Inc. 10 percent owner 1375 ENCLAVE PARKWAY, HOUSTON TX 77077